Anthriscifoldine B exhibits potential in pharmaceutical research due to its structural complexity and bioactive properties. It has shown promising antimicrobial activity in preliminary studies, particularly against Gram-positive bacteria. Its natural origin makes it a candidate for development in plant-based medicine and phytochemical drug discovery. Additionally, it may play a role in anti-inflammatory applications, supporting its evaluation in therapeutic agents targeting chronic inflammatory conditions. Further research is needed to explore its mechanism of action and possible use in clinical settings.